A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Milestones: 1952-1983 Bookmark and Share

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 

Milestones: 1952-1983

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Internship programs are a rite of summer for many high-achieving students. For five Caltech pre-med students, each hoping to make a mark in medicine, that rite led them to the City of Hope campus in Duarte, California, for an exceptional learning experience. The collaboration between the two high-profile resear...
  • Urinary tract stones are hard masses, or calculi, that form in the urinary tract and may cause pain, bleeding or an infection, or even block of the flow of urine. Urinary tract stones begin to form in a kidney and may enlarge in a ureter or the bladder. Depending on where a stone is located, […]
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...